ReviewPrzeglad gastroenterologiczny2026
Liver function disorders in pregnancy: physiology or pathology?
Review in Przeglad gastroenterologiczny, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The occurrence of abnormal liver function markers in pregnancy does not always indicate pathology. Many biochemical changes, such as increased alkaline phosphatase at the end of pregnancy or decreased albumin and bilirubin, are physiological and do not cause concern for the health of the pregnant woman and child. However, due to their similarity to the symptoms of liver diseases, their interpretation is a diagnostic challenge. It is important to take into account the characteristic clinical course of individual diseases and the stage of pregnancy in which they most often occur. This article discusses liver diseases specific to pregnancy, such as hyperemesis gravidarum, HELLP syndrome, preeclampsia and eclampsia, intrahepatic cholestasis of pregnancy, and acute fatty liver disease of pregnancy, as well as diseases independent of it, such as autoimmune hepatitis (AIH), primary biliary cirrhosis, and primary sclerosing cholangitis. Although symptoms of some diseases may improve during pregnancy, there is a risk of exacerbations in AIH, especially in the perinatal period, which requires close monitoring and adjustment of immunosuppressive therapy. Differential diagnosis should also include drug-induced liver injury and viral infections. A thorough medical history and analysis of symptoms are important. Early diagnosis and rapid therapeutic action in the discussed diseases are crucial to minimise the risk of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.